Second-Generation Antipsychotic Drugs for Children and Adolescents

J Nippon Med Sch. 2021 Mar 11;88(1):10-16. doi: 10.1272/jnms.JNMS.2021_88-108. Epub 2020 Sep 30.

Abstract

The effectiveness and safety of antipsychotics have not been fully established in children and adolescents. Many antipsychotics approved for use in adults are prescribed off-label to children and adolescents. We investigated the effectiveness and tolerability of antipsychotics for children and adolescents with schizophrenia and bipolar disorder. A literature review of the empirical evidence regarding the use of antipsychotics, particularly second-generation antipsychotics, in children and adolescents showed that these drugs were safe and effective for this population. Antipsychotics were similarly effective for treatment of schizophrenia and bipolar disorder in children and adolescents. When prescribing antipsychotics to this population, clinicians should consider adverse events and the discontinuation rate in treated patients. However, the current evidence shows a lack of consensus regarding the use of antipsychotics in children and adolescents.

Keywords: adolescents; antipsychotics; children; effectiveness; tolerability.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / adverse effects
  • Bipolar Disorder / drug therapy*
  • Child
  • Drug Tolerance
  • Female
  • Humans
  • Male
  • Safety
  • Schizophrenia, Childhood / drug therapy*
  • Treatment Outcome
  • Withholding Treatment / statistics & numerical data

Substances

  • Antipsychotic Agents